News

U.S. Marines with 1st Marine Aircraft Wing (MAW), perform COVID-19 prevention measures during Exercise Driven Thermite 21 at Marine Corps Air Station Futenma, Okinawa, Japan, Nov. 19, 2020. This exercise ensures that 1st MAW personnel are ready to plan and execute air operations in the Indo-Pacific by operating in a simulated environment. (U.S. Marine Corps photo by 1st Lt. Tess Lobossiere) - U.S. Marines with 1st Marine Aircraft Wing (MAW), perform COVID-19 prevention measures during Exercise Driven Thermite 21 at Marine Corps Air Station Futenma, Okinawa, Japan, Nov. 19, 2020. This exercise ensures that 1st MAW personnel are ready to plan and execute air operations in the Indo-Pacific by operating in a simulated environment. (U.S. Marine Corps photo by 1st Lt. Tess Lobossiere)

COVID Mitigation During Driven Thermite 21

OKINAWA, Japan – In mid-November hundreds of Okinawa, Iwakuni and Hawaii-based U.S. Marines with 1st Marine Aircraft Wing assembled for exercise Driven Thermite 21, a Wing level Command Post Exercise to validate the Aviation Combat Element Battle Staff’s ability to plan and execute aviation operations within the Indo-Pacific Command.

Read More

No Gym, No Problem

MCAS FUTENMA, Okinawa, Japan. — With gyms shut down and large-scale physical training together suspended for many Marines, units across the Corps have found unique ways to keep Marines active. For Marine Medium Tiltrotor Squadron 262 (VMM-262), it’s meant creating The Flying Tiger Running Challenge.

Read More

Running 24/7, and limited only by imagination: U.S. Marines put 3D printing skills to use in the fight against COVID-19

MCAS FUTENMA, Okinawa, Japan. — For Staff Sgt. Michael P. Burnham and Sgt. Blaine E. Garcia, a trailer-sized workspace filled with sweltering heat and the constant whine of over a dozen machines running at full speed is simply the setting for just another day. This day, however, sees these leaders bringing 3D printing to the fight for 1st Marine Aircraft Wing, using their manufacturing skills against COVID-19.

Read More